☆ 4.7 Letter

Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58

DIABETES CARE (2022)

Get Full Text
Add to Collection

Journal

DIABETES CARE
Volume 45, Issue 2, Pages E27-E29

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc21-1668

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. National Heart, Lung, and Blood Institute of the National Institutes of Health [T32HL12547]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.